Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Dec. 31, 2023 |
|
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
| Equity securities with no readily determinable fair value | $ 1,532 | $ 3,311 | |
| Realized investment losses, net | 1,836 | $ 56 | |
| VillageMD | |||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
| Equity securities with no readily determinable fair value | 900 | ||
| Realized investment losses, net | 1,800 | ||
| Separate Account Assets | |||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
| Separate accounts assets classified in Level 3, period increase (decrease), including transfers in and out of Level 3 | |||
| Separate Account Assets | Recurring | |||
| Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
| Expected liquidation period after inception | 10 years | ||